Home/Filings/4/0001209191-23-017023
4//SEC Filing

Cancelmi Daniel J 4

Accession 0001209191-23-017023

CIK 0000070318other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 9:21 PM ET

Size

26.8 KB

Accession

0001209191-23-017023

Insider Transaction Report

Form 4
Period: 2023-03-06
Cancelmi Daniel J
Principal Accounting Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-03-06+6,319399,134 total
  • Tax Payment

    Common Stock

    2023-03-06$60.62/sh2,487$150,762396,647 total
  • Exercise/Conversion

    Common Stock

    2023-03-06+8,673405,320 total
  • Tax Payment

    Common Stock

    2023-03-06$59.29/sh3,413$202,357401,907 total
  • Exercise/Conversion

    Common Stock

    2023-03-06+14,989416,896 total
  • Tax Payment

    Common Stock

    2023-03-06$59.29/sh5,899$349,752410,997 total
  • Exercise/Conversion

    Common Stock

    2023-03-06+71,810482,807 total
  • Tax Payment

    Common Stock

    2023-03-06$59.29/sh28,264$1,675,773454,543 total
  • Exercise/Conversion

    2021 February Restricted Stock Units

    2023-03-068,6738,673 total
    Common Stock (8,673 underlying)
  • Exercise/Conversion

    2020 February Performance-Based Restricted Stock Units

    2023-03-0671,8100 total
    Common Stock (71,810 underlying)
  • Exercise/Conversion

    2022 February Restricted Stock Units

    2023-03-066,31912,640 total
    Common Stock (6,319 underlying)
  • Exercise/Conversion

    2020 February Restricted Stock Units

    2023-03-0614,9890 total
    Common Stock (14,989 underlying)
Footnotes (8)
  • [F1]The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment settled on March 6, 2023.
  • [F2]Restricted stock units convert into common stock on a one-for-one basis.
  • [F3]The transaction reported reflects the withholding of shares of common stock in satisfaction of the Reporting Person's tax liability in connection with the settlement and vesting of time-based restricted stock units and performance-based restricted stock units granted under the 2019 Stock Incentive Plan.
  • [F4]Represents the closing price of the common stock of the Issuer on the vesting date.
  • [F5]The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment settled on March 6, 2023.
  • [F6]The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third and final 1/3 increment settled on March 6, 2023.
  • [F7]On February 26, 2020, the reporting person received a target grant of 44,965 performance-based restricted stock units, scheduled to vest on the third anniversary of the date of grant subject to the Company's attainment of specified performance goals and the level of achievement thereof. The performance goals were exceeded, and the award was certified at a payout of 71,810 units. The performance-based restricted stock units settled on March 6, 2023.
  • [F8]Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock.

Issuer

TENET HEALTHCARE CORP

CIK 0000070318

Entity typeother

Related Parties

1
  • filerCIK 0001396106

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 9:21 PM ET
Size
26.8 KB